Polianta LTD Beam Therapeutics Inc. Transaction History

Polianta LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$39.79 - $70.31 $429,732 - $759,348	10,800 New	10,800 $514,000
Q2 2022 Jul 19, 2022	SELL	$29.86 - $62.36 $480,746 - $1 Million	-16,100 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$53.73 - $82.16 $42,984 - $65,728	800 Added 5.23%	16,100 $922,000
Q4 2021 Jan 18, 2022	BUY	$68.02 - $99.06 $1.04 Million - $1.52 Million	15,300 New	15,300 $1.22 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.